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Abstract
The NHANES 2003–2006 has assessed iron and iodine status, 2 trace element nutrients of 
continued public health interest, in the US population. We investigated associations of 
sociodemographic (age, sex, race-ethnicity, education, income) and lifestyle variables (smoking, 
alcohol consumption, BMI, physical activity, dietary supplement use) with iron status indicators 
(serum ferritin, soluble transferrin receptor [sTfR], and body iron) in women 20–49 y (n = 2539, 
2513, 2509, respectively) and with urine iodine, a biomarker of iodine intake, in adults ≥20 y (n = 
3066). Significant correlations between the study variables and biomarkers were weak (|r| ≤0.24). 
Urine creatinine (uCr) was moderately significantly correlated with urine iodine (r = 0.52). The 
individual variables explained ≤5% of the variability in biomarker concentrations in bivariate 
analysis. In multiple regression models, sociodemographic and lifestyle variables together 
explained 4%–13% of the variability of iron indicators and 41% of the variability of urine iodine 
(uCr in the model). The adjusted estimated body iron was ~1 unit (mg/kg) lower in non-Hispanic 
black vs. non-Hispanic white women, and ~1 unit higher in women who smoked vs. those who did 
not, and in women consuming 1 vs. 0 alcoholic drinks/d. The adjusted estimated urine iodine 
concentration (uCr in the model) was 34% lower in non-Hispanic blacks vs. non-Hispanic whites, 
22% higher in supplement users vs. nonusers, and 11% higher with every 10 y increase in age. In 
summary, after adjusting for sociodemographic and lifestyle variables (and uCr in the iodine 
model), race-ethnicity retained a strong association with sTfR, body iron, and urine iodine; 
smoking and alcohol consumption with iron biomarkers; and supplement use and age with urine 
iodine.
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Iron and iodine are 2 important trace element nutrients required for health and development. 
Iron deficiency is linked to adverse consequences, such as reduced physical capacity, poor 
pregnancy outcomes, and negative effects on cognitive development among infants and 
adolescents. The reduction of iron deficiency in children and women of childbearing age, 2 
at-risk groups, is of continued public health interest and included among the objectives for 
Healthy People 2020 (1). Monitoring the iron status of the US population has been an 
important component since the inception of NHANES in 1971, and each survey has included 
a battery of hematologic and biochemical indicators (up to 2010) of iron status (2). In 2003, 
the measurement of serum soluble transferrin receptor (sTfR)5 was introduced, which allows 
the evaluation of iron status by the body iron model developed by Cook et al. (3). Body iron, 
estimated from the ratio of sTfR to serum ferritin (FER), assesses the full range of iron 
status of populations and is in positive balance (≥0 mg/kg) when there is residual storage 
iron or in negative balance (<0 mg/kg) when there is functional iron deficiency. The body 
iron methodology is also less affected by inflammation than the previously used ferritin 
model (4), which defined iron deficiency as having 2 abnormal out of 3 indicators (FER, 
transferrin saturation, and erythrocyte protoporphyrin). Different studies have assessed how 
iron status biomarkers in NHANES may be related to demographic and socioeconomic 
variables (5–9), dietary intake (10), and supplement use (11).
Iodine is required by the thyroid gland to produce thyroid hormones necessary for normal 
growth and brain development (12). The most critical period of iodine sufficiency is in utero 
through the first 2 y of life (13). It has been reported that subgroups of reproductive age 
women in the United States may be at risk for iodine deficiency (14). The WHO has defined 
nutritional iodine sufficiency for a population by the median urine iodine concentration (13). 
A biomarker of iodine intake, urine iodine has been used to monitor the iodine status of the 
US population in the NHANES since 1971 (15–18). However, little information is available 
from NHANES on the association of urine iodine concentrations with socioeconomic (14) 
and selected lifestyle variables such as supplement use (19), smoking (20), and salt 
consumption (21).
The CDC’s Second National Report on Biochemical Indicators of Diet and Nutrition in the 
US Population (Second Nutrition Report) used data from NHANES 2003–2006 to provide a 
descriptive analysis of the nutritional status of Americans by age, sex, and race-ethnicity 
(22). These analyses however, provide only limited interpretation of relative differences in 
nutritional status by demographic subgroup. As an extension of the Second Nutrition Report 
and in order to examine whether demographic differentials in nutritional status found in the 
Second Nutrition Report were related to and confounded by certain variables, we conducted 
an analysis to examine the association between key sociodemographic (age, sex, race-
ethnicity, education, and income) and lifestyle variables (supplement use, smoking, alcohol 
consumption, BMI, and physical activity) with biomarkers of iron (women 20–49 y) and 
iodine (men and women ≥20 y) status in US adults participating in NHANES 2003–2006. 
The results derived from our descriptive regression model may serve as a foundation to 
researchers who develop predictive regression models for specific hypotheses on nutrition 
and health using data from NHANES. Because iron and iodine both belong to the class of 
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trace elements, they are presented together in the Second Nutrition Report as well as in this 
publication. Companion publications in this journal supplement address the same questions 
for the other nutrient classes featured in the Second Nutrition Report.
SUBJECTS AND METHODS
The NHANES collects cross-sectional data on the health and nutritional status of the civilian 
non-institutionalized US population (23). The survey obtains a stratified, multistage, 
probability sample designed to represent the US population on the basis of age, sex, and 
race-ethnicity. All respondents gave their informed consent, and the NHANES protocol was 
approved by the NCHS Research Ethics Review Board. Details on what information is 
collected in NHANES are presented elsewhere (24).
Laboratory methods
The following iron and iodine status biomarkers were analyzed by the CDC laboratory 
during NHANES 2003–2006: FER, sTfR, body iron (calculated), and urine iodine. 
Information for each biomarker on the specimen matrix, the NHANES survey period and 
population assessed, the laboratory method used, and how we calculated body iron for this 
analysis is presented in Supplemental Table 1. Additional laboratory method details are 
provided elsewhere (25,26). Westgard-type QC multi-rules were used to judge assay 
performance (27).
Study variables
For bivariate analyses, we categorized the variables as follows: age (20–39 y, 40–59 y, and 
≥60 y for urine iodine; 20–39 y and 40–49 y for iron biomarkers); sex (men and women for 
urine iodine; women for iron biomarkers); race-ethnicity (Mexican American [MA], non-
Hispanic black [NHB], and non-Hispanic white [NHW]); education (<high school, high 
school, and >high school); family poverty income ratio (PIR: 0–1.85 [low], >1.85–3.5 
[medium], and >3.5 [high]) (28); smoking (serum cotinine ≤10 μg/L [nonsmoker], >10 μg/L 
[smoker]) (29); alcohol consumption (average daily number of “standard” drinks [1 drink ≈ 
15 g ethanol]: no drinks, <1 (not 0), 1–<2, and ≥2 drinks/d); BMI (kg/m2: <18.5 
[underweight], 18.5–<25 [normal], 25–<30 [overweight], and ≥30 [obese]) (30); physical 
activity (total metabolic equivalent task [MET]-min/wk from leisure time physical activity; 
none reported, 0–<500, 500–<1000, and ≥1000 MET-min/wk) (31); supplement use 
(reported taking a dietary supplement within the past 30 d: yes [user], no [non-user]).
Analytic sample
All participants examined in the mobile examination center aged 20 y and older in the 
NHANES 2003–2004 and 2005–2006 with at least 1 biomarker of interest were eligible for 
inclusion in the study. Depending on whether the biomarker was analyzed on the full sample 
or a subsample, data were available for ~2500 women (iron biomarkers) and ~3000 men and 
women (iodine) (Supplemental Table 2). Because we wanted to assess associations in the 
general US population, we did not exclude participants. Furthermore, considering all the 
potentially relevant exclusions in an analysis with multiple biomarkers would have been 
impractical. However, we verified that excluding participants who reported having had a 
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thyroid problem at some point (~1% of participants) did not substantially alter the geometric 
mean of urine iodine compared to not excluding them.
Statistical methods
As we used the same statistical methods for the series of papers presented in this 
supplement, the reader is referred to Sternberg et al. (32) for a detailed description of the 
methods and for a discussion of compromises taken in developing the multiple regression 
model due to the limited degrees of freedom, such as the number of covariates considered, 
the chosen form of continuous covariates, and the consideration of interactions between 
covariates. In short, we assessed bivariate associations between biomarkers and study 
variables by calculating Spearman correlations and by presenting the geometric means 
(arithmetic mean for body iron as its distribution was reasonably symmetric) and 95% CI 
across the variable categories. We used multiple linear regression to assess the impact of 
confounding and determine whether statistical significance persists after adjusting for 
differences in key variables. We arranged the independent variables into 2 sets or “chunks”: 
1) sociodemographic variables (age, sex, race-ethnicity, education level, and PIR) and 2) 
lifestyle variables (dietary supplement use, smoking, alcohol consumption, BMI, and 
physical activity level). We tested each chunk simultaneously to determine whether the 
independent variables (as a group) were related to the dependent variable; followed by a test 
for each individual variable while controlling for the other variables. We present the results 
of 3 regression models for each biomarker: simple linear regression (model 1), multiple 
linear regression model with the sociodemographic chunk (model 2), and multiple linear 
regression model with both the sociodemographic and lifestyle chunk (model 3). This allows 
for the comparison of results across all biomarkers. For urine iodine we assessed a fourth 
model, in which we included urine creatinine (uCr) as a covariate to adjust for the dilution of 
the spot urine. For each model we present the estimated percent change (absolute unit 
change for body iron) in biomarker concentrations with change in each covariate holding all 
other remaining covariates constant. Estimates were not reported if the minimum sample 
size of 42 was not reached (assumed average design effect of 1.4 multiplied by 30). Two-
sided P-values were flagged as statistically significant if <0.05.
RESULTS
A description of the civilian noninstitutionalized US population by the variables studied 
using NHANES 2003–2006 can be found in Supplemental Table 3. The continuous variables 
(age, PIR, smoking, alcohol consumption, BMI, and physical activity) were weakly 
significantly (|r| ≤0.24) or not at all significantly correlated with iron and iodine status 
biomarker concentrations (Table 1). As expected, urine creatinine was moderately 
significantly correlated with urine iodine (r = 0.52).
Bivariate methods (model 1) were used to test for significant differences among variable 
categories. Of the sociodemographic variables, only race-ethnicity and PIR had significant 
associations with FER and sTfR, while all 5 sociodemographic variables were significantly 
associated with urine iodine (Table 2). Of the lifestyle variables, smoking and alcohol 
consumption had significant associations with all 3 iron status indicators, while BMI was 
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significantly associated with sTfR and body iron only (Table 3). Physical activity was not 
significantly associated with iron status indicators. All 5 lifestyle variables had significant 
associations with urine iodine except for smoking status. Overall though, these individual 
variables explained little (r2 ≤5%) of the variability in biomarker concentrations.
Using multiple regression models, the sociodemographic variables together (model 2) 
explained up to 6% of the variability in iron status indicators (2% [FER and body iron] and 
6% [sTfR]) and 5% for urine iodine (Supplemental Table 4). Together, the 
sociodemographic and lifestyle variables (model 3) explained up to 13% of the variability in 
iron status indicators (4% [FER], 5% [body iron], and 13% [sTfR]) and 7% for urine iodine. 
When we also adjusted for uCr (model 4), 41% of the variability in urine iodine 
concentrations was explained. Adjusting for sociodemographic and lifestyle variables 
together generally led to an attenuation of beta coefficients (model 3 vs. model 2), 
suggesting that sociodemographic variables may capture some unmeasured effect that was 
shared with lifestyle variables. The additional adjustment for uCr in model 4 for urine iodine 
had different effects on beta coefficients depending on the variable: further attenuation for 
sex, PIR, alcohol consumption, and BMI; increase for age, race-ethnicity (NHB vs. NHW), 
and supplement use; and no change in the association with race-ethnicity (MA vs. NHW), 
education, smoking, and physical activity.
Because the log transformations may obscure the interpretation of the beta coefficients, we 
estimated the percent change in biomarker concentrations (change in mg/kg for body iron 
which was not log transformed) associated with each covariate. Based on the full regression 
model 3, only smoking and alcohol consumption were significantly and strongly associated 
with all 3 iron status indicators (Table 4 and Supplemental Fig. 1). We observed significant 
associations with only 2 markers for age (FER and body iron), race-ethnicity (NHB vs. 
NHW; sTfR and body iron), PIR (sTfR and body iron), and BMI (FER and sTfR). Physical 
activity was significantly associated with FER only; education, supplement use, and race-
ethnicity (MA vs. NHW) were not significantly associated with either of the iron 
biomarkers. The estimated change in body iron (model 3) was ~1 unit (mg/kg) lower in 
NHB vs. NHW women, and ~1 unit higher in women who smoked vs. did not smoke, and in 
women consuming 1 vs. 0 alcoholic drinks/d. Estimated FER (decreases with poor iron 
status) and sTfR (increases with poor iron status) concentrations were 7% lower and 19% 
higher in NHB vs. NHW women, 24% higher and 11% lower in smoking vs. nonsmoking 
women, and 21% higher and 6% lower in women consuming 1 vs. 0 alcoholic drinks/d, 
respectively. A 25% increase in BMI was associated with 7% and 6% higher FER and sTfR 
concentrations, respectively, but no change in body iron. A 10 y increase in age was 
associated with 8% higher FER concentrations and 0.2 mg/kg higher body iron.
Based on the full regression model 4, only age, race-ethnicity (NHB vs. NHW), supplement 
use, and alcohol consumption were significantly associated with urine iodine (Table 4 and 
Supplemental Fig. 2). The estimated urine iodine concentration (model 4) was 34% lower in 
NHB vs. NHW, 22% higher in supplement users vs. nonusers, 11% higher with every 10 y 
increase in age, and 7% lower in adults consuming 1 vs. 0 alcoholic drinks/d. Women had 
lower estimated urine iodine concentrations (~20%) compared to men for models 1–3, 
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however when we also adjusted for urine creatinine in model 4, the sex difference 
disappeared.
DISCUSSION
This analysis of iron and iodine status biomarkers in a nationally representative sample of 
American women (iron) and adults (iodine) participating in NHANES 2003–2006 showed 
the following after adjusting for key sociodemographic and lifestyle variables (and uCr for 
urine iodine): 1) race-ethnicity retained a significant association with selected iron status 
markers (sTfR and body iron) and urine iodine, with NHB (but not MA) having lower iron 
and iodine status compared to NHW; 2) smoking and alcohol consumption retained 
significant positive associations with iron status; and 3) supplement use and age retained 
significant positive associations with urine iodine.
Iron status
As the correlations between the iron status biomarkers and the sociodemographic and 
lifestyle variables were weak or not significant, it was not surprising that each individual 
variable explained ≤5% of the variability in biomarker concentrations in bivariate analyses, 
and that all variables together in a multiple regression model only explained between 4–13% 
of the biomarker variability. Other studies on determinants of iron status found similar R2 
estimates of <20% (33–34). Three variables––race-ethnicity, smoking, and alcohol 
consumption––emerged in the adjusted model as moderately strong and consistent correlates 
of iron status biomarkers.
Previous NHANES analyses of US women also found an association between iron 
deficiency (assessed by the ferritin or body iron model), FER or sTfR concentrations and 
race-ethnicity, with lower iron status in NHB compared to NHW women (6–9). Race-ethnic 
differentials in iron status may be related to dietary iron intake. Kant et al. showed that in 
NHANES III iron intake was lower in NHB (11.7 mg) compared to NHW (13.1 mg) 
women, but was similar in MA (12.5 mg) and NHW women (6). However, the observed 
association between FER and ethnicity remained unchanged after the authors added 24-h 
iron intake to their regression model. FER is an indicator of storage iron and may not reflect 
dietary intake; the absolute amount of dietary iron is less important than the kind of iron and 
type of meal in which it is found, because of large differences in heme and nonheme iron 
bioavailability, absorption, and influence of other dietary components (vitamin C and meat 
enhance, while phytate, fiber, and polyphenols inhibit the absorption of nonheme iron) (35). 
Consumption of heme iron has been shown to be a major and positive dietary determinant of 
iron stores (33,36), but nearly half of iron consumed by the US population is from grain 
products (nonheme) and only about one fifth is from meat, fish, and poultry (heme) (37).
Regular consumption of alcohol is known to disrupt normal iron metabolism, resulting in the 
excess deposition of iron in the liver in one-third of alcoholic subjects (38). A positive dose-
response relationship between the amount of alcohol consumed and FER concentrations has 
also been observed in the general population (33,34,39,40), suggesting that the effect of 
alcohol on iron metabolism may start at a lower level of consumption than was previously 
believed. We found not only a positive association of alcohol consumption (1 drink/d) with 
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FER (21% higher), but also with body iron (~1 mg/kg higher) and a negative association 
with sTfR (6% lower).
Smoking status has not been clearly established as a determinant of FER concentrations 
(41,42). A recent study reported that sTfR concentrations in young Belgian women were 
~9% lower in current smokers (33), which corresponded well with our finding of 10% lower 
estimated sTfR concentrations in women who smoked. As we saw with alcohol 
consumption, smoking was also associated with each iron status indicator (FER 24% and 
body iron ~1 mg/kg higher). It is not known to what extent dietary habits of smokers may 
contribute to this. Smokers are known to have higher meat intake and saturated fat 
consumption (43,44), indicators of more heme iron. Smoking may also have an independent 
effect on iron metabolism, unrelated to dietary intake.
A 25% increase in BMI in our study was associated with slightly higher estimated FER (7%) 
and sTfR (6%) concentrations, which is consistent with findings from NHANES III, where 
FER and C-reactive protein in adults progressively increased with BMI, while serum iron 
and transferrin saturation progressively decreased (45). Data from the Mexican Nutrition 
Survey also showed that obese compared to normal-weight women had a higher prevalence 
of ID (as measured by serum iron and transferrin saturation) despite similar dietary iron 
intakes in the two groups (46). An observational study in obese and nonobese adults found 
that the obesity-related hypoferremia (low serum iron) was not explained by differences in 
reported intake of heme and nonheme iron or intake of dietary variables that can affect iron 
absorption (47). Instead, the effect of obesity on iron status seems to parallel that of anemia 
of chronic disease, but without the anemia (45).
Iodine status
As seen with iron status indicators, the correlations between urine iodine and the 
sociodemographic and lifestyle variables were weak and in some cases not significant. It 
was not surprising to find a moderate and significant correlation between uCr and urine 
iodine, as creatinine has an established relationship with urine biomarker measurements and 
is generally used to adjust concentrations of urine analytes for variations in hydration status. 
However, because uCr concentrations differ greatly among different demographic groups, it 
has been suggested that for multiple regression analysis of population groups, the analyte 
concentration (unadjusted for uCr) be included in the model with uCr added as a separate 
independent variable (48). To allow separate interpretation of the effect of uCr on urine 
iodine, we evaluated each variable in a fourth model that adjusted for uCr in addition to the 
10 sociodemographic and lifestyle variables. In this model, 41% of the variability of urine 
iodine concentrations was explained, a much larger proportion than with model 3 (7%).
Three variables––race-ethnicity (NHB vs. NHW), supplement use, and age––emerged in the 
full regression model as correlates of iodine status. Race-ethnic and age differences in urine 
iodine concentrations have been reported previously throughout NHANES (15–18), however 
this is to our knowledge the first analysis that showed an association after adjusting for 
selected sociodemographic and lifestyle variables. We observed estimated urine iodine 
concentrations to be 11% higher for every 10 y increase in age. The lower urine iodine 
concentrations seen in NHB compared to NHW may be explained by the high prevalence 
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rate (70–75%) of lactase insufficiency and consequent lactose maldigestion among African-
Americans (49), which likely leads to self-imposed dietary restriction of milk and milk 
products. Dairy products are an important contributor to iodine status among women in the 
United States (14), as well as other populations (50,51). In the United States, NHB have the 
lowest and NHW the highest per capita intake of calcium, a proxy for consumption of milk 
and milk products (52).
We found higher urine iodine concentrations in supplement users vs. nonusers in each model 
(22% in model 4 vs. 14% in model 1). Gregory et al. showed that among reproductive age 
women in the United States, a much smaller percentage report consumption of supplements 
with iodine (20%) compared to any supplement (43%) (19). The crude measure of any 
supplement used in our analysis may be an indicator of generally healthy behavior, possibly 
giving preference to iodized salt.
Adult sex differences in iodine status are not well studied because most surveys are limited 
to children and/or women of reproductive age. Previous analyses of NHANES data showed 
that females had lower urine iodine concentrations compared to males (15–18). We also 
observed this sex differential in models 1 to 3. However, after we also included uCr into the 
model, the sex difference disappeared, possibly owing to the fact that men have higher 
muscle mass and therefore higher uCr concentrations (48). Other variables assessed in this 
analysis had weak or no association with urine iodine concentrations. We observed a 
negative association for alcohol consumption, however the estimated change in urine iodine 
concentrations was small (7%).
Summary
To our knowledge, this is the first study that examined the association of demographic, 
socioeconomic, and lifestyle variables on iron and iodine biomarkers available in the more 
recent continuous NHANES. We applied a systematic modeling approach and limited data 
driven decisions in the model building process to preserve the statistical properties of P-
values and coefficients (32). Additionally, our hierarchical chunk regression modeling 
provided a natural way to systematically assess the magnitude of an estimated change in 
biomarker concentration with change in a covariate, holding all other variables constant, 
across biomarkers. This systematic approach allowed us to assess the relative importance of 
10 sociodemographic and lifestyle variables across biomarkers in this paper and across other 
classes of nutritional indicators in other papers in this journal supplement (a summary table 
is presented in [32]). Associations of our study variables with the new indicator body iron 
are of particular interest because this indicator allows the evaluation of the full range of iron 
status of populations and is less affected by inflammation than FER (4).
Our analysis is not without limitations. Because of the cross-sectional nature of NHANES, 
we cannot draw any causal relationships between the biomarkers and variables. Our results 
could be confounded by unmeasured biological and genetic variables. In a separate analysis 
we investigated whether fasting or time of specimen collection as preanalytical variables and 
inflammation, kidney function, or pregnancy as physiological variables are associated with 
these biomarkers (53). Because of a limited number of degrees of freedom, we did not test 
for interactions between variables, between nutrients (e.g., iron and vitamin C), or between 
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variables and nutrients. Whether certain health conditions or health risk factors are 
associated with iron or iodine biomarkers was outside the scope of this investigation and so 
was the question whether dietary intake or intake of specific dietary supplements are 
associated with these biomarkers or interact with variables included in our analysis. While 
dietary intake of iron and iodine is known to be a major determinant of biomarkers, iron 
status indicators are only weakly correlated to recent dietary intake of total iron (35) and 
information on dietary intake of iodine is not readily available in NHANES 2003–2006. 
Furthermore, both intake and biomarkers are indicators of nutritional status. We chose to 
describe how biomarkers were associated with certain variables after adjusting for 
sociodemographic and lifestyle variables and within that scheme dietary intake was more 
naturally an outcome variable than a covariate. Nonetheless, we cannot answer the question 
whether the associations in our descriptive analysis are explained by intake or not. In 
summary, we conclude that in this adult population (women only for iron biomarkers) race-
ethnicity (NHB vs. NHW) was the only common variable that was associated with both iron 
and iodine biomarkers after adjusting for sociodemographic and lifestyle variables. 
Furthermore, iron biomarkers were associated with smoking and alcohol consumption, while 
urine iodine was associated with supplement use and age. This analysis provides a 
foundation for researchers that attempt to build predictive models to help answer specific 
hypotheses in the area of nutrition and health.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Table 1
Spearman correlation coefficients describing bivariate associations between each iron and iodine status 
biomarker and selected continuous sociodemographic and lifestyle variables for adults ≥20 y, NHANES 2003–
20061,2,3
Women 20–49 y of age Adults ≥20 y of age
Variable Serum ferritin Serum sTfR Body iron Urine iodine
Age 0.11* 0.03 0.14* 0.12*
PIR 0.06* −0.09* 0.03 −0.03
Smoking 0.05 −0.06 0.07* −0.03
Alcohol consumption4 0.07 −0.16* 0.09* −0.03
BMI 0.06* 0.24* 0.01 0.10*
Physical activity5 0.00 −0.02 −0.02 0.06*
Urine creatinine6 n/a n/a n/a 0.52*
1
Data for iodine only available for a 1/3 subsample
2
sTfR, soluble transferrin receptor; PIR, family poverty income ratio
3
Sample sizes for each biomarker by variable can be found in Supplemental Table 2; the total n for each biomarker was: 2539 (ferritin), 2513 
(sTfR), 2509 (body iron), and 3066 (urine iodine)
4
Alcohol consumption: calculated as average daily consumption [(quantity × frequency)/365.25]; 1 drink ≈ 15 g ethanol
5
Physical activity: calculated as total metabolic equivalent task (MET)-min/wk from self-reported leisure time physical activities
6
Correlation between urine iodine and urine creatinine was assessed because the concentration of urine-based analytes is often expressed per gram 
creatinine to correct for the urine dilution
*
Significant correlation; P <0.05
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Table 2
Unadjusted iron and iodine status biomarker concentrations by sociodemographic variable categories for 
adults ≥20 y, NHANES 2003–20061,2,3
Women 20–49 y of age Adults ≥20 y of age
Variable Serum ferritin Serum sTfR Body iron Urine iodine
μg/L mg/L mg/kg μg/L
Age, y
 20–39 38.1 (36.1 – 40.2) 3.42 (3.36 – 3.49) 5.51 (5.29 – 5.73) 135 (126 – 144)
 40–49 43.2 (39.0 – 47.7) 3.52 (3.38 – 3.65) 5.88 (5.46 – 6.30) n/a
 40–59 n/a n/a n/a 137 (128 – 147)
 ≥60 No data No data No data 187 (170 – 205)
 P-value4 0.05 0.17 0.06 <0.0001
 r2, %5 <1 <1 <1 2
Sex
 Men No data No data No data 162 (152 – 173)
 Women 39.9 (38.2 – 41.7) 3.46 (3.39 – 3.53) 5.65 (5.47 – 5.83) 133 (126 – 140)
 P-value n/a n/a n/a <0.0001
 r2, % n/a n/a n/a 1
Race-ethnicity6
 MA 33.5 (29.0 – 38.8) 3.46 (3.33 – 3.59) 5.02 (4.41 – 5.64) 164 (152 – 176)
 NHB 35.8 (32.9 – 38.9) 4.21 (4.09 – 4.33) 4.60 (4.27 – 4.92) 133 (122 – 145)
 NHW 42.0 (39.6 – 44.7) 3.33 (3.23 – 3.43) 5.96 (5.69 – 6.23) 150 (143 – 157)
 P-value 0.0040 <0.0001 0.0496 <0.0001
 r2, % 1 5 2 1
Education
 <High school 38.0 (32.8 – 44.0) 3.53 (3.40 – 3.67) 5.40 (4.80 – 6.01) 156 (143 – 170)
 High school 38.4 (35.8 – 41.3) 3.44 (3.34 – 3.54) 5.51 (5.20 – 5.81) 156 (144 – 169)
 >High school 41.0 (38.8 – 43.3) 3.44 (3.37 – 3.52) 5.76 (5.54 – 5.98) 139 (130 – 148)
 P-value 0.19 0.35 0.45 0.0252
 r2, % <1 <1 <1 <1
PIR7
 Low 36.5 (34.5 – 38.5) 3.62 (3.52 – 3.73) 5.16 (4.90 – 5.41) 148 (138 – 158)
 Medium 39.6 (36.0 – 43.5) 3.48 (3.36 – 3.59) 5.59 (5.19 – 5.99) 159 (148 – 170)
 High 42.4 (39.4 – 45.5) 3.34 (3.26 – 3.42) 5.98 (5.71 – 6.26) 138 (129 – 148)
 P-value 0.0056 <0.0001 0.42 0.0160
 r2, % <1 1 1 <1
1
Biomarker concentrations represent geometric means (arithmetic mean for body iron) and 95% CI; sTfR, soluble transferrin receptor; SI 
conversion factors are as follows: FER, ×2.247 (pmol/L); sTfR (no generally accepted conversion variable available); urine iodine, ×7.88 (nmol/L)
2
Data for iodine only available for a 1/3 subsample
3
Sample sizes for each biomarker by variable can be found in Supplemental Table 2; the total n for each biomarker was: 2539 (ferritin), 2513 
(sTfR), 2509 (body iron), and 3066 (urine iodine)
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4
P-value based on Wald F test, which tests whether at least one of the means across the categories is significantly different
5
r2 based on model 1, simple linear regression, using categories as shown
6
MA, Mexican American; NHB, non-Hispanic black; NHW, non-Hispanic white
7
PIR, family poverty income ratio: 0–1.85 (low); >1.85–3.5 (medium); >3.5 (high)
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Table 3
Unadjusted iron and iodine status biomarker concentrations by lifestyle variable categories for adults ≥20 y, 
NHANES 2003–20061,2,3
Women 20–49 y of age Adults ≥20 y of age
Variable Serum ferritin Serum sTfR Body iron Urine iodine
μg/L mg/L mg/kg μg/L
Supplement use4
 No 42.1 (39.3 – 45.0) 3.40 (3.33 – 3.47) 5.90 (5.62 – 6.17) 155 (147 – 163)
 Yes 37.7 (35.2 – 40.4) 3.51 (3.39 – 3.64) 5.38 (5.06 – 5.70) 136 (127 – 145)
 P-value5 0.0491 0.11 0.14 0.0006
 r2,%6 <1 <1 <1 1
Smoking7
 No 37.7 (35.7 – 39.7) 3.56 (3.48 – 3.64) 5.34 (5.12 – 5.57) 149 (141 – 158)
 Yes 46.7 (42.6 – 51.2) 3.20 (3.08 – 3.32) 6.47 (6.07 – 6.88) 138 (129 – 148)
 P-value 0.0005 <0.0001 0.0003 0.08
 r2,% 1 2 2 <1
Alcohol consumption8
 No drinks 36.5 (33.4 – 39.9) 3.64 (3.52 – 3.76) 5.14 (4.77 – 5.51) 168 (155 – 182)
 <1 (not 0) 40.0 (37.9 – 42.2) 3.41 (3.34 – 3.47) 5.71 (5.49 – 5.94) 140 (130 – 151)
 1–<2 56.3 (47.0 – 67.3) 3.16 (2.96 – 3.36) 7.23 (6.45 – 8.00) 137 (114 – 164)
 ≥2 NR10 NR NR 122 (108 – 137)
 P-value <0.0001 0.001 0.0002 0.0019
 r2,% 2 2 2 1
BMI9
 Underweight 43.0 (36.0 – 51.4) 3.00 (2.76 – 3.26) 6.45 (5.60 – 7.30) NR
 Normal weight 37.9 (35.4 – 40.5) 3.22 (3.14 – 3.32) 5.69 (5.39 – 5.99) 130 (120 – 140)
 Overweight 38.8 (35.2 – 42.8) 3.43 (3.30 – 3.55) 5.59 (5.15 – 6.02) 153 (140 – 167)
 Obese 43.0 (39.6 – 46.6) 3.80 (3.68 – 3.92) 5.59 (5.23 – 5.95) 156 (146 – 167)
 P-value 0.10 <0.0001 0.0312 <0.0001
 r2,% <1 5 <1 1
Physical activity11
 No activity 36.9 (34.1 – 40.0) 3.56 (3.42 – 3.71) 5.27 (4.88 – 5.66) 160 (149 – 171)
 0 – <500 41.3 (37.2 – 45.9) 3.48 (3.37 – 3.59) 5.75 (5.33 – 6.16) 134 (124 – 146)
 500–<1000 38.5 (34.5 – 43.0) 3.37 (3.21 – 3.53) 5.61 (5.13 – 6.09) 142 (124 – 162)
 ≥1000 42.0 (39.1 – 45.1) 3.38 (3.29 – 3.47) 5.90 (5.59 – 6.20) 144 (132 – 156)
 P-value 0.14 0.14 0.69 0.0082
 r2,% <1 <1 <1 1
1
Biomarker concentrations represent geometric means (arithmetic mean for body iron) and 95% CI; sTfR, soluble transferrin receptor; SI 
conversion factors are as follows: FER, ×2.247 (pmol/L); sTfR (no generally accepted conversion variable available); urine iodine, ×7.88 (nmol/L)
2
Data for iodine only available for a 1/3 subsample
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3
Sample sizes for each biomarker by variable can be found in Supplemental Table 2; the total n for each biomarker was: 2539 (ferritin), 2513 
(sTfR), 2509 (body iron), and 3066 (urine iodine)
4
“Supplement user” defined as participant who reported taking a dietary supplement within the past 30 d
5
P-value based on Wald F test, which tests whether at least one of the means across the categories is significantly different
6
r2 based on model 1, simple linear regression, using categories as shown
7
“Smoker” defined by serum cotinine concentration >10 μg/L
8
Alcohol consumption: calculated as average daily consumption [(quantity × frequency)/365.25]; 1 drink ≈ 15 g ethanol
9
BMI (kg/m2) definitions: <18.5(underweight); 18.5–<25 (normal weight); 25–<30 (overweight); and ≥30 (obese)
10
Estimate not reported due to small sample size (n <42)
11
Physical activity: calculated as total metabolic equivalent task (MET)-min/wk from self-reported leisure time physical activities
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Table 4
Estimated change in biomarker concentrations of iron and iodine status after adjusting for sociodemographic 
and lifestyle variables through chunk-wise modeling using data for adults ≥20 y, NHANES 2003–20061,2,3
Women 20–49 y of age Adults ≥20 y of age
Variable Serum ferritin Serum sTfR Body iron Urine iodine
Age: every 10 y increase
 Model 1 12.6* 1.2 0.4* 7.8*
 Model 2 10.4* 2.4* 0.3* 8.0*
 Model 3 7.6* 1.5 0.2* 6.3*
 Model 4 n/a n/a n/a 11.4*
Sex: women vs. men
 Model 1 n/a n/a n/a −18.2*
 Model 2 n/a n/a n/a −19.2*
 Model 3 n/a n/a n/a −25.5*
 Model 4 n/a n/a n/a 3.8
Race-ethnicity4: NHB vs. NHW
 Model 1 −14.8* 26.5* −1.4* −11.3*
 Model 2 −11.9* 24.8* −1.2* −11.7*
 Model 3 −6.6 18.8* −0.8* −12.0*
 Model 4 n/a n/a n/a −33.7*
Race-ethnicity4: MA vs. NHW
 Model 1 −20.2* 3.9 −0.9* 9.3*
 Model 2 −15.3* 2.5 −0.7 8.1
 Model 3 −3.9 −3.9 0.0 6.4
 Model 4 n/a n/a n/a 3.7
Education5: ≤HS vs. >HS
 Model 1 −6.7 0.8 −0.3 12.7*
 Model 2 −1.8 −2.7 0.0 7.1
 Model 3 −5.0 −2.6 −0.1 7.4
 Model 4 n/a n/a n/a 4.6
PIR6: every 2 unit decrease
 Model 1 −8.1* 4.7* −0.5* 4.5
 Model 2 −3.4 3.9* −0.3 5.6*
 Model 3 −4.2 3.4* −0.3* 8.4*
 Model 4 n/a n/a n/a 3.4
Supplement use7: yes vs. no
 Model 1 11.5* −3.1 0.5* 14.2*
 Model 3 6.0 −1.1 0.3 18.8*
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Women 20–49 y of age Adults ≥20 y of age
Variable Serum ferritin Serum sTfR Body iron Urine iodine
 Model 4 n/a n/a n/a 22.1*
Smoking8: yes vs. no
 Model 1 24.0* −10.1* 1.1* −7.4
 Model 3 24.2* −10.7* 1.1* −1.0
 Model 4 n/a n/a n/a −6.6
Alcohol consumption9: 1 vs. 0 drinks/d
 Model 1 28.8* −10.9* 1.3* −10.4*
 Model 3 21.3* −5.9* 0.9* −11.6*
 Model 4 n/a n/a n/a −7.1*
BMI10: 25% increase
 Model 1 5.7* 7.5* −0.0 9.5*
 Model 3 7.2* 6.0* 0.0 7.4*
 Model 4 n/a n/a n/a −0.5
Physical activity11: 750 vs. 150 MET-min/wk
 Model 1 2.2* −1.1* 0.1* −2.2*
 Model 3 2.9* −0.7 0.1 −0.5
 Model 4 n/a n/a n/a 0.1
1
Change represents percent change (%) in geometric mean for all biomarkers except for body iron where change in arithmetic mean represents 
units (mg/kg); sTfR, soluble transferrin receptor
2
Model 1, simple linear regression; model 2, multiple linear regression by adjusting for sociodemographic variables; model 3, multiple linear 
regression by adjusting for sociodemographic and lifestyle variables; change in covariate was carried out while holding any other variables in the 
model constant
3
Sample sizes for each biomarker by variable can be found in Supplemental Table 2 (model 1) and Supplemental Table 4 (models 2–4); the total n 
for each biomarker was: 2539 (ferritin), 2513 (sTfR), 2509 (body iron), and 3066 (urine iodine)
4




PIR, family poverty income ratio
7
“Supplement user” defined as participant who reported taking a dietary supplement within the past 30 d
8
“Smoker” defined by serum cotinine concentration >10 μg/L
9
Alcohol consumption: calculated as average daily consumption [(quantity × frequency)/365.25]; 1 drink ≈ 15 g ethanol
10
A 25% increase in BMI is comparable to a change from being normal weight to overweight
11
Physical activity: calculated as total metabolic equivalent task (MET)-min/wk from self-reported leisure time physical activities
*
Change is significantly different from zero; P <0.05
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